DNA X, Inc.
NASDAQSONM enters its Q4 2025 earnings call on Monday, May 18 carrying the most turbulent short-interest week of its recent history — and an unanswered question about whether it can file its quarterly report on time. The short-side story this week has been genuinely chaotic. Short interest more than doubled in five sessions, surging 129% week-on-week to a peak of around 69,000 shares on…
SONM short interest plummeted 11% to 3.7% of float, reversing a 129% surge from last week's volatile trading.
Snapshot as of 30 Jun 2026
SONM enters its Q4 2025 earnings call on Monday, May 18 carrying the most turbulent short-interest week of its recent history — and an unanswered question about whether it can file its quarterly report on time. The…
DNA X reports Q4 2025 results on May 18 against a backdrop of sharp price swings and a short interest picture in flux. The clearest setup signal is the recent volatility in short positioning. Short interest more than…
Short interest updated daily, real-time options flow, analyst consensus deltas, 13F positioning, ORTEX Alpha signals, and every article ORTEX publishes for SONM — free to start on ORTEX.
Sign up for free →Open SONM on ORTEX